PUBLISHER: KBV Research | PRODUCT CODE: 1462063
PUBLISHER: KBV Research | PRODUCT CODE: 1462063
Europe HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030
The Europe HIV Injection Market would witness market growth of 17.4% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe HIV Injection Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $178.5 Million by 2029. The UK market is exhibiting a CAGR of 16.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 18.2% during (2023 - 2030).
Antiretroviral therapy (ART), the known treatment for HIV, entails the daily administration of a combination of HIV medications. ART can lower the risk of HIV transmission and help individuals with the virus live longer, healthier lives, although it cannot cure HIV. The development of effective treatments for HIV has been a major focus of research and development efforts in the pharmaceutical industry for several decades.
Antiretroviral therapy functions by inhibiting viral replication within the body, thereby facilitating immune system restoration and diminishing the likelihood of AIDS-associated complications. One of the key components of ART is the use of HIV injections, which are administered to patients either alone or in combination with other antiretroviral drugs.
According to the European Centre for Disease Prevention and Control, in 2022, 37 of the 49 countries in the Region, including 26 in the European Union/European Economic Area (EU/EEA), reported an increase in HIV diagnoses compared to 2021, with some countries reporting record-high numbers in a single year. Therefore, their demand will continue to grow in this region throughout the forecast period.
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F. Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
Europe HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Europe HIV Injection Market, by Distribution Channel
- 1.4.2Europe HIV Injection Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Europe HIV Injection Market by Distribution Channel
- 4.1Europe Hospital Pharmacy Market by Country
- 4.2Europe Drugs Stores & Retail Pharmacies Market by Country
- 4.3Europe Others Market by Country
Chapter 5.Europe HIV Injection Market by Country
- 5.1Germany HIV Injection Market
- 5.1.1Germany HIV Injection Market by Distribution Channel
- 5.2UK HIV Injection Market
- 5.2.1UK HIV Injection Market by Distribution Channel
- 5.3France HIV Injection Market
- 5.3.1France HIV Injection Market by Distribution Channel
- 5.4Russia HIV Injection Market
- 5.4.1Russia HIV Injection Market by Distribution Channel
- 5.5Spain HIV Injection Market
- 5.5.1Spain HIV Injection Market by Distribution Channel
- 5.6Italy HIV Injection Market
- 5.6.1Italy HIV Injection Market by Distribution Channel
- 5.7Rest of Europe HIV Injection Market
- 5.7.1Rest of Europe HIV Injection Market by Distribution Channel
Chapter 6.Company Profiles
- 6.1GlaxoSmithKline PLC (GSK)
- 6.1.1Company Overview
- 6.1.2Financial Analysis
- 6.1.3Regional Analysis
- 6.1.4Research & Development Expense
- 6.1.5SWOT Analysis
- 6.1Gilead Sciences, Inc.
- 6.1.1Company overview
- 6.1.2Financial Analysis
- 6.1.3Research & Development Expenses
- 6.1.4SWOT Analysis
- 6.2ImmunityBio, Inc.
- 6.2.1Company Overview
- 6.2.2Financial Analysis
- 6.2.3Regional Analysis
- 6.2.4Research & Development Expenses
- 6.2.5SWOT Analysis
- 6.3F. Hoffmann-La Roche Ltd.
- 6.3.1Company Overview
- 6.3.2Financial Analysis
- 6.3.3Segmental and Regional Analysis
- 6.3.4Research & Development Expense
- 6.3.5SWOT Analysis
- 6.4Theratechnologies Inc.
- 6.4.1Company Overview
- 6.4.2Financial Analysis
- 6.4.3Research & Development Expenses
- 6.4.4SWOT Analysis
- 6.5Viriom, Inc.
- 6.5.1Company Overview
- 6.5.2SWOT Analysis
- 6.6AbbVie, Inc.
- 6.6.1Company Overview
- 6.6.2Financial Analysis
- 6.6.3Regional Analysis
- 6.6.4Research & Development Expense
- 6.6.5SWOT Analysis
- 6.7Brii Biosciences Limited
- 6.7.1Company Overview
- 6.7.2Financial Analysis
- 6.7.3Research & Development Expenses
- 6.7.4SWOT Analysis
- 6.8Shionogi & Co., Ltd.
- 6.8.1Company Overview
- 6.8.2Financial Analysis
- 6.8.3Research & Development Expenses
- 6.8.4SWOT Analysis
- 6.9Boehringer Ingelheim International GmbH
- 6.9.1Company Overview
- 6.9.2Financial Analysis
- 6.9.3Regional & Segmental Analysis
- 6.9.4Research & Development Expenses
- 6.9.5SWOT Analysis
LIST OF TABLES
- TABLE 1Europe HIV Injection Market, 2019 - 2022, USD Million
- TABLE 2Europe HIV Injection Market, 2023 - 2030, USD Million
- TABLE 3Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 4Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 5Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 6Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 7Europe Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 8Europe Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 9Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 10Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 11Europe HIV Injection Market by Country, 2019 - 2022, USD Million
- TABLE 12Europe HIV Injection Market by Country, 2023 - 2030, USD Million
- TABLE 13Germany HIV Injection Market, 2019 - 2022, USD Million
- TABLE 14Germany HIV Injection Market, 2023 - 2030, USD Million
- TABLE 15Germany HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 16Germany HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 17UK HIV Injection Market, 2019 - 2022, USD Million
- TABLE 18UK HIV Injection Market, 2023 - 2030, USD Million
- TABLE 19UK HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 20UK HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 21France HIV Injection Market, 2019 - 2022, USD Million
- TABLE 22France HIV Injection Market, 2023 - 2030, USD Million
- TABLE 23France HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 24France HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 25Russia HIV Injection Market, 2019 - 2022, USD Million
- TABLE 26Russia HIV Injection Market, 2023 - 2030, USD Million
- TABLE 27Russia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 28Russia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 29Spain HIV Injection Market, 2019 - 2022, USD Million
- TABLE 30Spain HIV Injection Market, 2023 - 2030, USD Million
- TABLE 31Spain HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 32Spain HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 33Italy HIV Injection Market, 2019 - 2022, USD Million
- TABLE 34Italy HIV Injection Market, 2023 - 2030, USD Million
- TABLE 35Italy HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 36Italy HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 37Rest of Europe HIV Injection Market, 2019 - 2022, USD Million
- TABLE 38Rest of Europe HIV Injection Market, 2023 - 2030, USD Million
- TABLE 39Rest of Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 40Rest of Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 41Key Information - GlaxoSmithKline PLC
- TABLE 42Key Information - Gilead Sciences, Inc.
- TABLE 43Key Information - ImmunityBio, Inc.
- TABLE 44Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 45Key Information - Theratechnologies Inc.
- TABLE 46Key Information - Viriom, Inc.
- TABLE 47Key information - AbbVie, Inc.
- TABLE 48Key Information - Brii Biosciences Limited
- TABLE 49Key Information - Shionogi & Co., Ltd.
- TABLE 50Key Information - Boehringer Ingelheim International GmbH
